SI1325022T1 - Metoda za pripravo 21-hidroksi-6,19-oksidoprogesterona (21oh-6op) - Google Patents

Metoda za pripravo 21-hidroksi-6,19-oksidoprogesterona (21oh-6op)

Info

Publication number
SI1325022T1
SI1325022T1 SI200130675T SI200130675T SI1325022T1 SI 1325022 T1 SI1325022 T1 SI 1325022T1 SI 200130675 T SI200130675 T SI 200130675T SI 200130675 T SI200130675 T SI 200130675T SI 1325022 T1 SI1325022 T1 SI 1325022T1
Authority
SI
Slovenia
Prior art keywords
oxidoprogesterone
hydroxy
preparation
phosphorlated
acylated
Prior art date
Application number
SI200130675T
Other languages
English (en)
Slovenian (sl)
Inventor
Gerardo Burton
Carlos P Lantos
Adriana Silvia Veleiro
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of SI1325022T1 publication Critical patent/SI1325022T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI200130675T 2000-09-18 2001-09-17 Metoda za pripravo 21-hidroksi-6,19-oksidoprogesterona (21oh-6op) SI1325022T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00119494 2000-09-18
PCT/EP2001/010734 WO2002022646A2 (en) 2000-09-18 2001-09-17 Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op)

Publications (1)

Publication Number Publication Date
SI1325022T1 true SI1325022T1 (sl) 2007-04-30

Family

ID=8169774

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200130675T SI1325022T1 (sl) 2000-09-18 2001-09-17 Metoda za pripravo 21-hidroksi-6,19-oksidoprogesterona (21oh-6op)

Country Status (13)

Country Link
US (4) US7071328B2 (https=)
EP (1) EP1325022B1 (https=)
JP (1) JP2004509131A (https=)
AT (1) ATE344273T1 (https=)
AU (2) AU1817902A (https=)
CA (1) CA2419960A1 (https=)
DE (1) DE60124289T2 (https=)
DK (1) DK1325022T3 (https=)
ES (1) ES2271090T3 (https=)
IL (2) IL154776A0 (https=)
PT (1) PT1325022E (https=)
SI (1) SI1325022T1 (https=)
WO (1) WO2002022646A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1325022T1 (sl) * 2000-09-18 2007-04-30 Applied Research Systems Metoda za pripravo 21-hidroksi-6,19-oksidoprogesterona (21oh-6op)
SI1330468T1 (sl) * 2000-09-18 2007-10-31 Serono Lab Ĺ˝veplovi analogi 21-hidroksi-6,19-oksido-progesterona (21oh-6op) za zdravljenje preseĺ˝ka glukokortikoidov
WO2007106385A2 (en) * 2006-03-10 2007-09-20 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment
EP1862468A1 (de) * 2006-06-02 2007-12-05 Bayer Schering Pharma Aktiengesellschaft Kristallines 11beta-(4-Acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-on
DE102009034367A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034366A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034368A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010007719A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
MX2015004606A (es) 2012-10-09 2017-04-04 Avery Dennison Corp Adhesivos y metodos relacionados.
US20210355154A1 (en) * 2018-09-28 2021-11-18 The Regents Of The University Of Michigan Halogenated Cholesterol Analogues and Methods of Making and Using Same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3036068A (en) * 1960-01-06 1962-05-22 Syntex Sa C-6, 19-steroidal lactones
LU77457A1 (https=) * 1977-05-31 1979-01-19
US4814333A (en) * 1987-07-28 1989-03-21 The Trustees Of Dartmouth College Method for treatment of hypercortisolemic, depressed patients
GB9606016D0 (en) * 1996-03-22 1996-05-22 Smithkline Beecham Plc Novel use
EP0903146A1 (en) * 1997-09-23 1999-03-24 Applied Research Systems ARS Holdings N.V. 21-Hydroy-6,19-oxidoprogesterone (210h-60p) as antiglucocorticoid
ATE332696T1 (de) * 1997-10-06 2006-08-15 Univ Leland Stanford Junior Methode zur behandlung von durch glycocorticoidstörungen verursachten psychosen
SI1330468T1 (sl) * 2000-09-18 2007-10-31 Serono Lab Ĺ˝veplovi analogi 21-hidroksi-6,19-oksido-progesterona (21oh-6op) za zdravljenje preseĺ˝ka glukokortikoidov
SI1325022T1 (sl) * 2000-09-18 2007-04-30 Applied Research Systems Metoda za pripravo 21-hidroksi-6,19-oksidoprogesterona (21oh-6op)

Also Published As

Publication number Publication date
ATE344273T1 (de) 2006-11-15
ES2271090T3 (es) 2007-04-16
AU2002218179B2 (en) 2006-11-16
AU1817902A (en) 2002-03-26
EP1325022B1 (en) 2006-11-02
PT1325022E (pt) 2006-12-29
CA2419960A1 (en) 2002-03-21
WO2002022646A2 (en) 2002-03-21
IL154776A (en) 2007-07-04
WO2002022646A3 (en) 2002-06-06
JP2004509131A (ja) 2004-03-25
DE60124289T2 (de) 2007-09-06
US20050277769A1 (en) 2005-12-15
US20040092733A1 (en) 2004-05-13
US20090216008A1 (en) 2009-08-27
DK1325022T3 (da) 2007-02-19
EP1325022A2 (en) 2003-07-09
IL154776A0 (en) 2003-10-31
US7071328B2 (en) 2006-07-04
WO2002022646A9 (en) 2002-09-19
DE60124289D1 (de) 2006-12-14
US20070249826A1 (en) 2007-10-25

Similar Documents

Publication Publication Date Title
MXPA02012931A (es) Proceso para preparar un elastomero.
AU2002224893A1 (en) Method for producing a part and device for carrying out this method
SG147286A1 (en) Manufacture of polyglumate-therapeutic agent conjugates
AU2002357049A1 (en) Methods for preparing 0-desmethylvenlafaxine
AU2002358929A1 (en) Conversational dealing system using reference numbers for all messages .
MXPA03009935A (es) Metodos e intermedios para preparar inhibidores 4-aminoquinolina de cetp.
AU1817902A (en) Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op)
MXPA03002010A (es) Metodo para producir un epoxido.
ZA200102070B (en) Process for preparing resorcinol derivatives.
MXPA03001800A (es) Proceso para la preparacion de fenilacetonitrilos sustituidos.
AU2001233703A1 (en) Diethyloctandioldicarbamates and diethyloctandioldiallophanates, method for the production and use thereof
AU2956302A (en) A process for the preparation of taxan derivatives
WO2001007408A3 (fr) Nouveau procede de preparation de composes benzoperhydroisoindole
IL156331A0 (en) A process for the preparation of paclitaxel
MXPA03002926A (es) Proceso para la sintesis de 2,2,6,6,-tetrametil-4--oxipiperidina.
ZA200104999B (en) Method for the production of formaldehyde.
MX234329B (es) Metodo para producir n-fosfonometilglicina.
AP2004002991A0 (en) Delimbing apparatus.
AU2001250429A1 (en) Method for producing 2-alkyl-3-chlorophenols
MXPA03009210A (es) PROCEDIMIENTO PARA LA PREPARACIoN DE OXABISPIDINAS.
ZA200101529B (en) Process for the preparation of isoindoline.
AU2001256674A1 (en) N-(heterocycle-methyl)alkylamine derivative, process for producing the same, andbactericide
MY123576A (en) Process for the selective n-formylation of n-hydroxylamines
AU2001284016A1 (en) Signaling device, preferably for explosion-prone locations
MXPA03003068A (es) Proceso para preparacion de tiofenoles.